Pentraxin 3 concentrations of the mothers with preterm premature rupture of membranes and their neonates, and early neonatal outcome


Akin M. A., GÜNEŞ T., COBAN D., ÖZGÜN M. T., AKGÜN H., Kurtoglu S.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, cilt.28, sa.10, ss.1170-1175, 2015 (SCI-Expanded) identifier identifier identifier

Özet

Background: Pentraxin 3 (PTX3) is an acute phase reactant which has been used to detect intra-amniotic infections (IAI) in pregnancy, but the prognostic value of PTX3 concentrations on neonates has not been studied. We aimed to investigate the relationship between maternal PTX3-neonatal PTX3 concentrations and early neonatal outcome.